Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea by �씠寃쎌썝 et al.
Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235
Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on
Novel Genomic Islands PAGI-15 and -16 in South Korea
Jun Sung Hong,a,b Eun-Jeong Yoon,b Hyukmin Lee,b Seok Hoon Jeong,b Kyungwon Leeb
Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Koreaa; Department of Laboratory Medicine and Research Institute of
Bacterial Resistance, Yonsei University College of Medicine, Seoul, South Koreab
A total of 431 Pseudomonas aeruginosa clinical isolates were collected from 29 general hospitals in South Korea in 2015. Antimi-
crobial susceptibility was tested by the disk diffusionmethod, andMICs of carbapenems were determined by the agar dilution
method. Carbapenemase genes were amplified by PCR and sequenced, and the structures of class 1 integrons surrounding the
carbapenemase gene cassettes were analyzed by PCRmapping. Multilocus sequence typing (MLST) and pulsed-field gel electro-
phoresis (PFGE) were performed for strain typing. Whole-genome sequencing was carried out to analyze P. aeruginosa genomic
islands (PAGIs) carrying the blaIMP-6, blaIMP-10, and blaGES-24 genes. The rates of carbapenem-nonsusceptible and carbapen-
emase-producing P. aeruginosa isolates were 34.3% (148/431) and 9.5% (41/431), respectively. IMP-6 was the most prevalent
carbapenemase type, followed by VIM-2, IMP-10, and GES-24. All carbapenemase genes were located on class 1 integrons of 6
different types on the chromosome. All isolates harboring carbapenemase genes exhibited genetic relatedness by PFGE (similar-
ity> 80%); moreover, all isolates were identified as sequence type 235 (ST235), with the exception of two ST244 isolates by
MLST. The blaIMP-6, blaIMP-10, and blaGES-24 genes were found to be located on two novel PAGIs, designated PAGI-15 and PAGI-
16. Our data support the clonal spread of an IMP-6-producing P. aeruginosa ST235 strain, and the emergence of IMP-10 and
GES-24 demonstrates the diversification of carbapenemases in P. aeruginosa in Korea.
Pseudomonas aeruginosa is an opportunistic pathogen thatcauses various nosocomial infections, including sepsis, pneu-
monia, and urinary tract infections (1). Treatment of P. aerugi-
nosa infections is often difficult because of the intrinsic drug re-
sistance of P. aeruginosa and the ability of this pathogen to acquire
genes for antimicrobial resistance determinants (2). Carbapenems
are used as last-resort drugs for the treatment of infections caused
by multidrug-resistant P. aeruginosa, due to their high affinity for
penicillin-binding proteins, stability to various -lactamases, and
ability to easily pass through the bacterial outer membrane. How-
ever, the increasing use of carbapenems has resulted in the emerg-
ing phenomenon of carbapenem resistance (3).
P. aeruginosa can become resistant to carbapenems by reduced
permeability of the outer membrane due to loss of substrate-spe-
cific outer membrane porin OprD, frequently accompanied by
AmpC hyperproduction and overexpression of efflux systems (4),
along with acquisition of genes encoding carbapenemases (5).
While the molecular mechanism of carbapenem resistance is geo-
graphically variable, diverse classes of carbapenemase have been
increasingly identified in P. aeruginosa, including class A (KPC
and GES variants), class B (IMP, VIM, and NDM metallo--lac-
tamases [MBLs]), and class D (OXA variants) (6). The MBLs, in
particular IMP and VIM enzymes, are the most widespread car-
bapenemases in P. aeruginosa (7), with IMP-6 exclusively present
in South Korea (8).
Carbapenemase genes are found often on integrons in P.
aeruginosa clinical isolates. Integrons are prevalent in Gram-neg-
ative clinical isolates and offer the ability to capture and excise
gene cassettes, frequently including antibiotic resistance determi-
nants, to the bacterial host (9). However, integrons accomplish
mobility only when they are associated with a specific mobile ge-
netic element, such as a transposon, conjugative plasmid, or
genomic island (10). The genomic islands in P. aeruginosa are
mostly integrative and conjugative elements (ICEs) and are
named according to their characteristics, i.e., P. aeruginosa patho-
genicity island or the name of their host, i.e., Liverpool epidemic
strain genomic islands or, more broadly, i.e., P. aeruginosa
genomic island (PAGI) (11). Thus far, 14 PAGIs have been iden-
tified (12). These genomic islands typically carry genes for inte-
gration, transfer, and maintenance, which confer self-transfer-
ability to the composite ICE, along with genes conferring
metabolic, virulence, and heavymetal resistance capability, which
offer extra benefit to the bacterial host. AlthoughPAGIs associated
with antimicrobial resistance are rare, some examples have been
identified, e.g., derivatives of PAGI-1 and PAGI-2 (13).
Two nucleotide sequence-based bacterial typing techniques,
pulsed-field gel electrophoresis (PFGE) and multilocus sequence
typing (MLST), are considered to be the gold standards for use in
epidemiological studies. The PFGE provides fingerprints of entire
bacterial genomes by restriction enzyme mapping to determine
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epidemiological relationships of an outbreak in detail, while the
MLST method gives strain lineages based on DNA fragments of
seven housekeeping genes which allow fewer and larger groups
feasible for global comparison (14). Two international high-risk
P. aeruginosa clones, sequence type 111 (ST111) and ST235, are
responsible for the dissemination of carbapenemase genes world-
wide (15), with GES-type carbapenemase-producing P. aerugi-
nosa ST235 in Spain (16) and IMP-6-producing P. aeruginosa
ST235 in South Korea (8). Meanwhile, ST175 and ST244 carrying
genes that confer resistance to carbapenems have also been reported
to be responsible for regional dissemination; as a result, it could be
considered that they were associated with high-risk clones (17). To-
gether with PFGE andMLST, relatively high-cost whole-genome se-
quencing (WGS) is now commonly used for epidemiological studies
expecting an incomparable power of discrimination (14).
The aims of this study were to investigate the prevalence of
carbapenemase genes in P. aeruginosa clinical isolates recovered
from general hospitals in South Korea in 2015 and to determine
the genetic environments surrounding the carbapenemase genes
and epidemiological characteristics of carbapenemase-producing
P. aeruginosa (CP-PA) clinical isolates.
MATERIALS AND METHODS
Bacterial strains. A total of 431 nonduplicated P. aeruginosa clinical iso-
lates were collected from 29 general hospitals located in 11 cities and
provinces in South Korea between June and August 2015. The isolates
were recovered from blood (n  33), respiratory specimens (n  180),
urine (n  93), pus (n  97), and other specimens (n  28). Bacterial
species were identified by matrix-assisted laser desorption ionization–
time of flightmass spectrometry (MALDIMS) using a BrukerMALDIMS
instrument (Bruker, Billerica, MA). Species identification was made only
when the log score of the species was above 2.0; otherwise, partial se-
quences of the 16S rRNA gene were analyzed.
Antimicrobial susceptibility testing. Antimicrobial susceptibilities
were tested by the disk diffusion method by following the Clinical and
Laboratory Standards Institute guidelines (18). Briefly, disks (Oxoid Ltd.,
Basingstoke, UK) containing the following antimicrobial agents were
used: piperacillin, ceftazidime, cefepime, aztreonam, gentamicin, tobra-
mycin, amikacin, ciprofloxacin,meropenem, imipenem, and colistin. The
MICs ofmeropenem and imipenemwere determined by the agar dilution
method on Mueller-Hinton agar (Becton, Dickinson and Company,
Sparks,MD). P. aeruginosaATCC 27853 and Escherichia coliATCC 25922
were used as control strains.
Identification of carbapenem resistance determinants. The genes
encoding IMP-, VIM-, and NDM-type MBLs, KPC- and GES-like serine
-lactamases (19), and OprD outer membrane porin were amplified by
PCR in carbapenem-nonsusceptible P. aeruginosa clinical isolates. PCR
amplicons were purified using a QIAquick PCR purification kit (Qiagen,
Hilden, Germany) and sequenced using an Applied Biosystems 3730xl
DNA analyzer (Applied Biosystems, Foster City, CA) to identify the vari-
ant types of each carbapenemase family. Sequences were compared with
those in GenBank (http://www.ncbi.nlm.nih.gov/GenBank) using the
BLAST network service.
Integronmapping and sequencing. The structures of the class 1 inte-
grons carrying the carbapenemase gene cassettes were determined by PCR
mapping and sequencing using the primers listed in Table 1.
MLST. PCR amplification and sequencing of partial fragments of seven
housekeeping genes (acsA, aroE, guaA, mutL, nuoD, ppsA, and trpE) were
performed, and the experimentally determined nucleotide sequences of both
strands were compared to preexisting sequences in the MLST database to
assign allele numbers and STs (http://pubmlst.org/paeruginosa).
PFGE.Agarose plugs containing XbaI-digested genomicDNA from P.
aeruginosa clinical isolates were prepared and DNA fragments were sepa-
rated for 20 h at 6 V/cm at 11°C using a CHEF-DRII system (Bio-Rad,
Hercules, CA). Pulsing was carried out with initial and final pulse times of
0.5 s and 30 s, respectively. A lambda ladder (Bio-Rad) was used as a DNA
size marker. Band patterns were analyzed with UVIband/Map software
(UVItech Ltd., Cambridge, UK) and used to generate dendrograms based
on the unweighted pair groupmethod using arithmetic averages from the
Dice coefficient.
Southern blot and hybridization. Southern blotting was performed
to determine the locations of the carbapenemase genes. Briefly, I-CeuI or
S1 nuclease-digested DNA was blotted onto nylon membranes (Zeta-
Probe blotting membranes; Bio-Rad) and hybridized with probes specific
for the carbapenemase genes or 16S rRNA. The probes were obtained via
PCR amplification as described above. Probe labeling, hybridization, and
detection were performedwith a digoxigenin DNA labeling and detection
kit (Roche Diagnostics, Indianapolis, IN).
WGS. For bacterial whole-genome sequencing (WGS), single-mole-
cule real-time (SMRT) sequencing was carried out on a PacBio RSII in-
strument (Pacific Biosciences, Menlo Park, CA). Genomic DNA was ex-
tracted from the P. aeruginosa strains using a Wizard genomic DNA
purification kit (Promega,Madison,WI). After extraction, DNA shearing
was performed using a g-TUBE apparatus (Covaris, Inc., Woburn, MA),
and the fragments were purified by using 0.45 the final volume of
washed Agencourt AMPure XP magnetic beads (Beckman Coulter Inc.,
Brea, CA). SMRTbell template libraries were subsequently prepared, and
adapter ligation was performed, followed by exonuclease digestion of in-
completely ligated products. Reads with lengths that were less than 50 bp
were filtered out after acquisition of the sequencing data; the minimum
polymerase read quality was set to 0.75. De novo genome assembly of
PacBio SMRT reads was performed with the PacBio SMRT analysis soft-
ware suite (version 2.3.0) (20). Briefly, the hierarchical genome assembly
process was used with default parameters and a seed read length cutoff of
6 kb. Following assembly, individual contigs with duplicate sequences on
their 5= and 3= ends were manually trimmed. Similarly, overlapping se-
quences were manually trimmed and joined based on sequence similarity
to form circular fragments. Following chromosome and plasmid circular-
ization, the sequences were polished using Quiver. In this program, the
raw reads are mapped back to the chromosome and plasmid sequences to
validate the assembly and resolve any remaining sequence errors. The
annotations of coding sequences, tRNA sequences, and rRNA sequences
were performed using the NCBI Prokaryotic Genome Annotation Pipe-
line (http://www.ncbi.nlm.nih.gov/books/NBK174280).
Accession number(s). The nucleotide sequence data reported in this
paper are available in the GenBank nucleotide database under accession
numbers KX196167 (PAGI-16 carrying the blaIMP-6 gene), KX196168
(PAGI-15 carrying the blaGES-24 gene), and KX196169 (PAGI-16 carrying
the blaIMP-10 gene).
RESULTS
Antimicrobial resistance profiles of the P. aeruginosa isolates.
Of the 431 P. aeruginosa clinical isolates examined, 283 (65.7%)
were found to be susceptible to carbapenems. The remaining 148
isolates (34.3%) that were nonsusceptible to imipenem and/or
meropenem were classified by PCR into two groups: carbapen-
emase-producing P. aeruginosa (CP-PA) (n  41), whose mem-
bers carried the blaIMP, blaVIM, or blaGES gene, and non-carbapen-
emase-producing P. aeruginosa (NCP-PA; n  107), whose
members did not. Twenty isolates (18.7%) in the NCP-PA group
had an OprD porin loss. The vast majority (40/41) of the clinical
isolates in the CP-PA group exhibited an extensively drug-resis-
tant phenotype and were resistant to all drugs tested except colis-
tin (Fig. 1). Moreover, the CP-PA group showed extremely high
rates of nonsusceptibility to piperacillin (97.6%, compared to
62.6% in the NCP-PA group and 10.2% in the carbapenem-sus-
ceptible group), ceftazidime (97.6%, compared to 29.9% and
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7.1%, respectively), ciprofloxacin (100%, compared to 70.1% and
13.8%, respectively), and amikacin (100%, compared to 23.4%
and 3.5%, respectively).
Presence of the carbapenemase gene and its correlation with
carbapenem susceptibility. The most prevalent gene, blaIMP-6,
was identified in 36 isolates;moreover, another subtype, blaIMP-10,
was identified in one isolate. P. aeruginosa clinical isolates harbor-
ing blaIMP-6 exhibited higher resistance to meropenem (MICs, 64
to 256 g/ml; MIC50, 256 g/ml; and MIC90, 256 g/ml)
than to imipenem (MICs, 16 to 256 g/ml; MIC50, 16 g/ml; and
MIC90, 32 g/ml). Isolate BP14, carrying blaIMP-10, had similar
carbapenem MICs: for meropenem, 256 g/ml, and for imi-
penem, 16 g/ml. The products encoded by blaIMP-6 and blaIMP-1
differ by one amino acid, with the former having a Ser216-Gly
substitution compared with the latter. Similarly, the product en-
coded by blaIMP-10 exhibits a single Val49-Phe substitution com-
pared with the product encoded by blaIMP-1.
The blaVIM-2 gene was identified in three isolates. These three
isolates had meropenemMICs ranging from 16 to 128 g/ml and
imipenemMICs ranging from16 to 256g/ml. The blaGES-24 gene
was identified in one isolate, and the isolate showed resistance to
meropenem (MIC, 128 g/ml) and imipenem (MIC, 64 g/ml).
TABLE 1 Primers used in this study for integron characterization
Target Primer Nucleotide sequence (5=–3=) Positiona Reference
intI INT1-mF GCCTGTTCGGTTCGTAAGCT 908/927 This study
INT1-F CCAAGCTCTCGGGTAACATC 462/481
INT1-R CATGAAAACCGCCACTGC 997/1014
qacE1 qacE1-F GAAAGGCTGGCTTTTTCTTG 3/22 This study
qacE1-R GCAGCGACTTCCACGATG 311/328
ereA ereA2-F TTGAGCGATTTTCGGATACC 269/288 This study
ereA2-R GGCATGAATCCTCCTTACCA 1071/1090
qac qac-F CAATCTTTGGCGAGGTCATC 29/48 8
qac-R CGCTGACCTTGGATAGCAG 307/325
catB3 catB3-F AAGGCAAGCTGCTTTCTGAG 29/48 21
catB3-R AACGATAGCGTAAGGCTCCA 440/459
aadA1 aadA1-F ACATCATTCCGTGGCGTTAT 284/303 This study
aadA1-R AGGTTTCATTTAGCGCCTCA 489/508
aacA4 aacA4-F TGACCTTGCGATGCTCTATG 12/31 This study
aacA4-R CTGGCGTGTTTGAACCATGT 470/489
aacA7 aacA7-F CAGGCCTGTTGAAACTACCG 21/40 22
aacA7-R CTTGAGCAACCTCCGTGAAT 414/433
blaOXA OXA-1F TATCTACAGCAGCGCCAGTG 54/73 21
OXA-1R TGCACCAGTTTTCCCATACA 635/654
OXA-2F CGATAGTTGTGGCAGACGAA 128/147
OXA-2R CTTGACCAAGCGCTGATGT 564/582
tniC TniC-R TTTCCGAGCGAACAGTCGCT 229/248 22
blaIMP IMP-1F AAGGCGTTTATGTTCATACTTCG 95/117 19
IMP-1R TTTAACCGCCTGCTCTAATGTAA 677/699
blaVIM VIM-2F ATCATGGCTATTGCGAGTCC 46/65 19
VIM-2R ACGACTGAGCGATTTGTGTG 775/794
blaKPC KPC-F GTCACTGTATCGCCGTCTAGTTC 3/25 19
KPC-R TGGTGGGCCAATAGATGATT 919/938
blaGES GES-F ATGCGCTTCATTCACGCAC 1/19 This study
GES-R CTATTTGTCCGTGCTCAGGA 864/845
blaNDM NDM-F GCCCAATATTATGCACCCGG 9/28 19
NDM-R CTCATCACGATCATGCTGGC 649/668
oprD oprD-F GGAACCTCAACTATCGCCAAG 120/99 This study
oprD-R GTTGCCTGTCGGTCGATTAC 17/1328
a Coordinates refer to the first base of each gene.
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Of note, this strain had a truncated OprD by a novel insertion
sequence, ISPA67. Considering the relatively low carbapenem
MICs for 20P. aeruginosa strains having only the porin loss, 1 to 32
g/ml (MIC50, 8 g/ml, and MIC90, 16 g/ml) for meropenem
and 4 to 32 g/ml (MIC50, 16 g/ml, and MIC90, 32 g/ml) for
imipenem, the elevated carbapenem MICs were mostly by GES-
24. GES-24 differs from GES-1 by two substitutions, Met62-Thr
and Gly170-Ser, and the latter change is the same as in the carba-
penem-hydrolyzing GES-5.
Strain typing for the CP-PA isolates. All CP-PA isolates were
identified as ST235 (allele profile, 38-11-3-13-1-2-4), with the ex-
ception of two isolates: isolate JNH6, which carried blaVIM-2, and
isolate IH2, which carried blaGES-24. These two isolates were iden-
tified as ST244 (17-5-12-3-14-4-7), which is very different from
ST235 (see Table S1 in the supplemental material). The ST235
CP-PA isolates sharedmore than 80% similarity as determined by
PFGE analysis, and the remaining two ST244 isolates also exhib-
ited close relatedness (similarity, 90%). The ST235 and ST244
isolates did not show significant relatedness (similarity,	70%) to
each other (Fig. 2).
Genetic contexts of the class 1 integrons.The blaIMP-6, blaIMP-10,
blaVIM-2, and blaGES-24 geneswere located on class 1 integrons as gene
cassettes, and the structures determined by PCR mapping are indi-
cated in Fig. 3. The blaIMP-6 gene in all 36 isolates was carried by
InIMP-6D (intI1-blaIMP-6-qac-aacA4-catB3-aacA4-blaOXA-1-
aadA1). This class 1 integron was identified in 2008 in one P.
aeruginosa ST235 clinical isolate from South Korea (21). The
blaIMP-10 gene in isolate BP14 composed a new class 1 integron,
InIMP-10 (intI1-blaIMP-10-qac-aacA4-catB3-aacA4-blaOXA-1-
aadA1). Between the integron integrase coding gene and the
gene cassettes, an integron-associated 136-bp attI recombina-
tion site was identified.
The blaVIM-2 gene cassette was found in three different inte-
grons: In559 (intI1-aacA7-blaVIM-2-dhfa-aadA5), InVIM-2JH5
(intI1-aadB-blaVIM-2-aacA4-orf-ereA), and InVIM-2JH6 (intI1-
aacA4-blaVIM-2-aacA4-fosC-blaOXA-2-qac). In559 was first identi-
fied in P. aeruginosa ST235 clinical isolates from Russia in 2002
(22), and InVIM-2JH5 and InVIM-2JH6 class 1 integrons were first
found in P. aeruginosa and Pseudomonas putida isolates, respec-
tively, from South Korea (unpublished data; GenBank accession
numbers EF207719 for InVIM-2JH5 and AY907717 for InVIM-
2JH6). Notably, In559 was distinct from the other class 1 inte-
grons that culminate with qac
1 in that the Tn5090 tniC gene
(also called tniR of Tn402) for the 3= conserved sequence (CS)
indicates a distinct evolutionary path driving the excision and
addition of gene cassettes (23). Isolate IH2 was found to har-
bor a novel integron, InGES-24 (intI1-aacA4-aadB-blaGES-24-
aacA4-blaOXA-2).
Two novel genomic islands, PAGI-15 and PAGI-16. By
Southern blotting using I-CeuI macrorestriction-digested frag-
ments, the blaIMP-6, blaIMP-10, blaVIM-2, and blaGES-24 genes were
verified to be chromosome carried in all CP-PA isolates (data not
shown). Probes specific for the carbapenemase genes did not
bind to any S1 nuclease-treated plasmids. To further charac-
terize the genomic environments of the class 1 integrons, WGS
was conducted using the PacBio RSII platform for three P.
aeruginosa isolates: KMU11 of blaIMP-6, BP14 of blaIMP-10, and
IH2 of blaGES-24.
The draft genome sequences of KMU11 were composed of
nine contigs, and three (a total of 6.9 Mb in size) of those carried
the genes for ribosomal proteins indicating that they were carried
on a chromosome. The class 1 integron InIMP-6Dwas found on a
chromosome in a 1.6-Mb contig possessing together the genes
encoding ribosomal proteins S6, S9, S15, S18, S20, L9, L13, L21,
L25, L27, and L31.Moreover, the integron was in a novel genomic
island, PAGI-16, which was 95,029 bp long. PAGI-16 was inte-
FIG 1 Antimicrobial susceptibilities of P. aeruginosa clinical isolates. (A) Carbapenem-susceptible isolates (n  283); (B) carbapenem-nonsusceptible non-
carbapenemase producers (n 107); (C) carbapenem-nonsusceptible carbapenemase producers (n 41).
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grated at the end of the tRNAGly gene, like the other genomic
islands found in P. aeruginosa (11), and flanked at its end by 20-bp
direct repeats (DR), GATTCCCTTCACCCGCTCCA (Fig. 4A).
PAGI-16 in isolate KMU11 had a GC content of 61.4% and
contained 99 open reading frames (ORFs), including a cluster
of nine genes originating from the clc element, which is also
found in PFGI-1 of Pseudomonas fluorescens (24). The clc ele-
ment integrates through the attB site using a bacteriophage
P4-like integrase; this site is situated in between two tandem
tRNAGly genes in the 3= end (11). The cluster also contains 10
genes associated with genome instability, such as genes for in-
tegrases and transposases and insertion sequences; eight genes
for antimicrobial resistance, i.e., two copies of aacA4 plus
aadA1, catB3, cmx, sul1, and blaOXA-1, together with blaIMP-6,
which are mostly found in the class 1 integron between bp
57464 and 77106; and genes encoding hypothetical proteins,
which comprise the rest of the sequences.
Isolate BP14 had a 7.1-Mb circularized chromosome without
any plasmid, and the class 1 integron InIMP-10 was found within
a 69,208-bp 5= portion of a genomic island sharing 99.99%nucleic
acid identity with PAGI-16 in isolate KMU11. This portion was
integrated at the end of the tRNAGly gene, and the 20-bp DR
GATTCCCTTCACCCGCTCCA was present in the 5= end as in
KMU11. PAGI-16 was ended by IS6100, and a truncated wspC,
encoding a biofilm formation methyltransferase WspC, was
found downstream (Fig. 4A). The 1,269-bp wspC gene encodes
the biofilm formation methyltransferase WspC, and the left
619 bp was found 3.3 Mb away from the portion together with
the rest of PAGI-16 in the opposite direction. The 26,701-bp 3=
portion of PAGI-16 in isolate BP16 was identical to that in
KMU11, and the 20-bp DR sequence was found, indicating
chromosomal inversion by a duplication-insertion of IS6100
(25). All of PAGI-16 in isolate BP14 had the same GC con-
tent, 61.4%.
IH2 had a 7.3-Mb circularized chromosome devoid of any
plasmid. In the chromosome, the class 1 integron InGES-24 was
located within a 118,715-bp genomic island designated PAGI-15.
The location of PAGI-15 was the same as that of PAGI-16, next to
FIG 2 Characteristics of chromosome-encoded carbapenemase-producing P. aeruginosa clinical isolates. Strains which were subjected to whole-genome
sequencing are shown in bold.
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the tRNAGly gene, but the DR was 27 bp, AGGGTTCGATTCCC
TTCGCCCGCTCCA (Fig. 4A). TheGC content of the PAGI-16
was 61.3%, slightly lower than that of the PAGI-15. This genomic
island shared the backbone with PAGI-16, presenting 99.99% nu-
cleic acid identity excluding the class 1 integron and a short puta-
tive prophage possessing nine ORFs located in the 3= end of the
genomic island (Fig. 4A). PAGI-16 contained 116 putative ORFs,
mostly shared with PAGI-15 except 11 antimicrobial resistance
genes, two copies of aacA4, aadB, strA, strB, tet(G), cmx, two
copies of sul1, blaOXA-2, and blaGES-24.
FIG 3 Schematic representation of class 1 integrons carrying the carbapenemase gene cassettes. Yellow arrows, integrase; red arrows, genes for resistance;
magenta arrows, qacE1; green arrow, tniC gene; blue arrow, a gene for tyrosine recombinase XerD; dotted line, unknown nucleotide sequences.
FIG 4 Schematic representation of genomic islands in strains IH2, KMU11, and BP14. (A) The sequences of genomic islands of P. aeruginosa isolates were
aligned using BLASTN and compared using Artemis Comparison Tool (32). The conserved regions (95% identity) are indicated in red. Arrowhead, location
of chromosomal inversion due to duplication-insertion of IS6100. (B) Schematic mechanism for the large chromosomal inversion mediated by duplication of
IS6100. In a chromosome carrying PAGI-16, catalyzed 3=-OH groups of IS6100 (white circle) targeted the 5= phosphate in the wspC gene (black circle) located
elsewhere. The replication broke the cointegration, leading to the duplication in the opposite direction of IS6100 and a chromosomal inversion. The final
chromosomal structure became 5=PAGI-16-IS6100-5=wspC and 3=PAGI-16-IS6100 (opposite direction)-3=wspC. White arrow, PAGI-16; black arrow,
IS6100; gray arrow, wspC.
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DISCUSSION
A nationwide survey in 2009 reported that the carbapenem resis-
tance rate in P. aeruginosa was 35.8% (138/386) and 8.0% (31/
386) of the strains produced carbapenemases IMP-6 (n 30) and
VIM-2 (n 1) (8). In this surveillance, a similar rate ofCP-PAwas
found, 9.5% (41/431). Among CP-PA strains, prevalence of
blaIMP-6-producing P. aeruginosa has been detected exclusively in
South Korea. IMP-6 production by the bacterial host results in a
higherMIC for meropenem than for imipenem. This is due to the
Ser216-Gly substitution, which results in increased hydrolysis of
meropenem compared with that of imipenem (26). Interestingly,
meropenem is highly recommended for treating Gram-negative
bacterial infections, rather than imipenem (27), and meropenem
usage is increasing faster than that of imipenem (28). It is likely
that antibiotic selective pressure leads to the predominance of
IMP-6 in P. aeruginosa.
Clonal diversity of the epidemic isolates, which consisted
mostly of ST235 isolates presenting indistinguishable PFGE pat-
terns, allowed us to understand that the dissemination of IMP-6
was mostly by clonal dissemination of the P. aeruginosa ST235
isolates possessing the gene. The gene cassette array added more
evidence for that, showing all IMP-6-positive strains possessed an
identical class 1 integron, InIMP-6D (intI1-blaIMP-6-qac-aacA4-
catB3-aacA4-blaOXA-1-aadA1). Interestingly, the gene cassette ar-
ray of this class 1 integron resembled that of the integron intI1-
blaIMP-6-qac-aacA4-blaOXA-1-aadA1 in epidemic strains of P.
aeruginosa isolated in 2009 (8) (Fig. 3).
The second most prevalent carbapenemase was VIM-2, al-
though it was identified in only three isolates. The blaVIM-2 gene
was sporadically identified to be associated with unrelated inte-
grons in P. aeruginosa of two different STs, ST235 and ST244, each
with different PFGE patterns (Fig. 2). These results suggest that
blaVIM-2 dissemination was due not to clonal spread but rather to
an occasional occurrence. Interestingly, In559, one of the three
class 1 integrons carrying the blaVIM-2 gene cassette, had a distinct
3= end, matured by tniC of Tn5090 instead of the usual 3= CS with
qacE1. This finding likely indicates that In559 has been devel-
oped through a different evolutionary scheme used by Tn5090. A
similar blaVIM-2 gene cassette-carrying integron, which was iden-
tified as an ancestral class 1 integron 3= ended by the tniC gene, was
identified in a P. aeruginosa strain isolated in India in 2003 (23).
The precise epidemiological relationship of the unusual integrons
in our strain and in the Indian strain is unclear, since no ST infor-
mation could be obtained for the case.
This surveillance study enabled the first observation of IMP-10
and GES-24, indicating diversification of carbapenemases in P.
aeruginosa in South Korea. The blaIMP-10-associated integron has
previously been identified in P. aeruginosa in Japan (29). We ini-
tially suspected that the first identification of blaIMP-10 reflected a
traveler carrier; however, after inspecting the genomic environ-
ment of this gene, we concluded that this gene appearance was a
result of spontaneous nucleotide substitutions independently
from blaIMP-1, a G640A substitution resulting in Gly216-Ser mu-
tation for IMP-6 in PAGI-16 of KMU11 and G145T leading to
Val49-Phe mutation in IMP-10 in PAGI-16 of BP14. Indeed, this
conclusion is supported by two additional pieces of evidence.
First, InIMP-6D and InIMP-10 have the same genetic context, with
the exception of theMBL gene cassettes (blaIMP-6 and blaIMP-10) be-
tween the 5= CS and the 3= CS (Fig. 3). Second, PAGI-16, which
was found to carry the blaIMP-6 gene (GenBank accession number
KX196167), and PAGI-16, which was found to carry the blaIMP-10
gene (GenBank accession number KX196169), exhibited a high
degree of homology based onWGS results and shared most of the
conserved regions (95% identity) (Fig. 4A).
So far, sixGES-lactamases, namely, GES-2, -4, -5, -6, -14, and
-18, have been shown to present detectable carbapenemase activ-
ity (6). This activity is predominantly a factor of substitutions of
amino acid residues 104 and 170. TheGES-24 enzyme has Gly170,
like GES-5, which results in high affinity for carbapenems and
high turnover rates due to the low rate constants for acylation
and deacylation (30). TheGES-5 producersKlebsiella pneumoniae
and E. coli have been found in South Korea (31), but the genes were
on very different integrons. The genes for GES-24 in Enterobacter
cloacae and Acinetobacter baumannii from Japan are available in
GenBank (last updated on 13 May 2016), but to the best of our
knowledge, this is the first description of GES-24 in P. aeruginosa.
Interestingly, PAGI-15 and PAGI-16 were found to differ only
by their integrons. It is likely that the two genomic islands derived
from a common origin. They once possessed a backbone possess-
ing a clc-like element, into which two unrelated integrons were
later integrated. Moreover, PAGI-16 in one isolate was found to
have split into two parts by large chromosomal inversion that
resulted in duplication-insertion of the IS6100 gene in the oppo-
site direction (Fig. 4B). Similar IS6100-mediated large chromo-
somal inversions have been found in P. aeruginosa clinical isolates
and are likely to be involved in phenotypic adaptations of the
different strains to the environment (25).
PAGI-15 and -16 in this study were found in P. aeruginosa
belonging to ST244 and ST235. These genomic islands have
shared origin evidenced by the same backbone in spite of the dis-
tinct STs of the host P. aeruginosa. Interestingly, a genomic island
having a same backbone is found also in the chromosome of P.
aeruginosa ST395 isolated in France in 1997 (GenBank accession
number CP013993). The genomic island has a class 1 integron
possessing one gene cassette, aadB. This highly mobile genomic
island is likely to have a key role for capturing and disseminating
the multiple antibiotic resistance genes in P. aeruginosa belonging
to various STs, similar to the case with PAGI-1 and -2 (13).
In conclusion, our data indicate that IMP-6 is highly prevalent
in CP-PA ST235 isolates. Moreover, our results clearly demon-
strate thatWGSmethodology can be used to identify the genomic
environments associated with resistance determinants, which
promises to shed light onmany epidemiological questions regard-
ing the mechanism of dissemination of resistance determinants.
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